Skip to main content
SpringerLink
Log in

Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette–Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study

  • Research Article
  • Published:
Frontiers of Medicine Aims and scope Submit manuscript

Abstract

The prevalence of tuberculosis infection among adolescents born after terminating the Bacillus Calmette–Guérin (BCG) booster vaccination in China was estimated using tuberculin skin testing (TST) and QuantiFERON-TB Gold assay (QFT) to investigate the influence of neonatal BCG vaccination on the performance of TST. Data analysis was conducted for 2831 eligible participants aged 5–15 years from the baseline survey of a population-based multi-center prospective study. The prevalence rates of TST (induration = 10 mm) and QFT positivity were 9.3% (264/2827) and 2.5% (71/2831), respectively. The rate of QFT indeterminate result was 2.2% (62/2831). The overall agreement between TST and QFT was low (concordance = 88.0%; ? coefficient = 0.125). Only TST was positively associated with BCG vaccination with an adjusted odds ratio of 1.71 [95% confidence interval, 1.26–2.31]. A history of close contact with patients of active TB was significantly associated with positivity for TST and QFT. Our results suggested that BCG neonatal vaccination still affects TST performance, and a twostep approach might be considered for TB infection testing among adolescents in China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993; 17(6): 968–975

    Article  CAS  PubMed  Google Scholar 

  2. Menzies D. What does tuberculin reactivity after bacille Calmette-Guérin vaccination tell us? Clin Infect Dis 2000; 31(Suppl 3): S71–S74

    Article  PubMed  Google Scholar 

  3. Pai M, Riley LW, Colford JM Jr. Interferon-γ assays in the immunodiagnosis of tuberculosis: a systematic review. Lancet Infect Dis 2004; 4(12): 761–776

    Article  CAS  PubMed  Google Scholar 

  4. Andersen P, Munk ME, Pollock JM, Doherty TM. Specific immunebased diagnosis of tuberculosis. Lancet 2000; 356(9235): 1099–1104

    Article  CAS  PubMed  Google Scholar 

  5. Wang L, Liu J, Chin DP. Progress in tuberculosis control and the evolving public-health system in China. Lancet 2007; 369(9562): 691–696

    Article  PubMed  Google Scholar 

  6. Gao L, Lu W, Bai L, Wang X, Xu J, Catanzaro A, Cárdenas V, Li X, Yang Y, Du J, Sui H, Xia Y, Li M, Feng B, Li Z, Xin H, Zhao R, Liu J, Pan S, Shen F, He J, Yang S, Si H, Wang Y, Xu Z, Tan Y, Chen T, Xu W, Peng H, Wang Z, Zhu T, Zhou F, Liu H, Zhao Y, Cheng S, Jin Q; LATENTTB-NSTM study team. Latent tuberculosis infection in rural China: baseline results of a population-based, multicentre, prospective cohort study. Lancet Infect Dis 2015; 15(3): 310–319

    Article  PubMed  Google Scholar 

  7. Gao L, Jin Q. Differences in BCG vaccination and tuberculin skintest positivity—Authors’ reply. Lancet Infect Dis 2015; 15(9): 1003–1005

    Article  PubMed  Google Scholar 

  8. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A, Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005; 54(RR-15): 49–55

    Google Scholar 

  9. Cheng S, Wang G, Wang L, Zhou L. Guidance of Tuberculin Skin Test. Bengjing: People’s Medical Publishing House, 2014

    Google Scholar 

  10. Sheng YL. China Statistical Yearbook—2010. Beijing: China Statistics Press, 2010

    Google Scholar 

  11. World Health Organization. Growth reference 5–19 years. 2007. http://www.who.int/growthref/who2007_bmi_for_age/en/ (Accessed October 8, 2016)

  12. Kang YA, Lee HW, Yoon HI, Cho B, Han SK, Shim YS, Yim JJ. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. JAMA 2005; 293(22): 2756–2761

    Article  CAS  PubMed  Google Scholar 

  13. Mandalakas AM, Detjen AK, Hesseling AC, Benedetti A, Menzies D. Interferon-γ release assays and childhood tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2011; 15(8): 1018–1032

    Article  CAS  PubMed  Google Scholar 

  14. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, Mahomed H. The utility of an interferon γ release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J 2011; 30(8): 694–700

    Article  PubMed  Google Scholar 

  15. World Health Organization. Use of tuberculosis interferon-γ release assays (IGRAs) in low-and middle-income countries: policy statement. 2011. http://whqlibdoc.who.int/publications/2011/9789241502672_eng (Accessed August 9, 2016)

  16. Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K; IGRA Expert Committee; Centers for Disease Control and Prevention (CDC). Updated guidelines for using interferon γ release assays to detect Mycobacterium tuberculosis infection — United States, 2010. MMWR Recomm Rep 2010; 59(RR-5): 1–25

    PubMed  Google Scholar 

  17. National Institute for Health and Care Excellence. Clinical diagnosis and management of tuberculosis, and measures for its prevention and control. Manchester: NICE, 2011

  18. Lighter J, Rigaud M, Eduardo R, Peng CH, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics 2009; 123(1): 30–37

    Article  PubMed  Google Scholar 

  19. Tsiouris SJ, Austin J, Toro P, Coetzee D, Weyer K, Stein Z, El-Sadr WM. Results of a tuberculosis-specific IFN-γ assay in children at high risk for tuberculosis infection. Int J Tuberc Lung Dis 2006; 10 (8): 939–941

    CAS  PubMed  Google Scholar 

  20. Bianchi L, Galli L, Moriondo M, Veneruso G, Becciolini L, Azzari C, Chiappini E, de Martino M. Interferon-γ release assay improves the diagnosis of tuberculosis in children. Pediatr Infect Dis J 2009; 28(6): 510–514

    Article  PubMed  Google Scholar 

  21. Nelson LJ, Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004; 8(5): 636–647

    CAS  PubMed  Google Scholar 

  22. Starke JR. Childhood tuberculosis: ending the neglect. Int J Tuberc Lung Dis 2002; 6(5): 373–374

    PubMed  Google Scholar 

  23. Piñeiro R, Mellado MJ, Cilleruelo MJ, García-Ascaso M, Medina-Claros A, García-Hortelano M. Tuberculin skin test in bacille Calmette-Guérin-vaccinated children: how should we interpret the results? Eur J Pediatr 2012; 171(11): 1625–1632

    Article  PubMed  Google Scholar 

  24. Rieder HL. Epidemiological Basis of TB Control. Paris: International Union Against Tuberculosis and Lung Disease, 1999. 26–43

    Google Scholar 

  25. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax 2002; 57(9): 804–809

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10(11): 1192–1204

    CAS  PubMed  Google Scholar 

  27. Mahomed H, Hawkridge T, Verver S, Geiter L, Hatherill M, Abrahams DA, Ehrlich R, Hanekom WA, Hussey GD; SATVI Adolescent Study Team. Predictive factors for latent tuberculosis infection among adolescents in a high-burden area in South Africa. Int J Tuberc Lung Dis 2011; 15(3): 331–336

    CAS  PubMed  Google Scholar 

  28. Connell TG, Ritz N, Paxton GA, Buttery JP, Curtis N, Ranganathan SC. A three-way comparison of tuberculin skin testing, Quanti-FERON-TB gold and T-SPOT.TB in children. PLoS One 2008; 3 (7): e2624

    Article  PubMed  PubMed Central  Google Scholar 

  29. Gao L, Bai L, Liu J, Lu W, Wang X, Li X, Du J, Chen X, Zhang H, Xin H, Sui H, Li H, Su H, He J, Pan S, Peng H, Xu Z, Catanzaro A, Evans TG, Zhang Z, Ma Y, Li M, Feng B, Li Z, Guan L, Shen F, Wang Z, Zhu T, Yang S, Si H, Wang Y, Tan Y, Chen T, Chen C, Xia Y, Cheng S, Xu W, Jin Q; LATENTTB-NSTM study team. Annual risk of tuberculosis infection in rural China: a population-based prospective study. Eur Respir J 2016; 48(1): 168–178

    Article  CAS  PubMed  Google Scholar 

  30. Joshi M, Monson TP, Joshi A, Woods GL. IFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers. Ann Am Thorac Soc 2014; 11(3): 296–302

    Article  CAS  PubMed  Google Scholar 

  31. Slater ML, Welland G, Pai M, Parsonnet J, Banaei N. Challenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers. Am J Respir Crit Care Med 2013; 188(8): 1005–1010

    Article  PubMed  PubMed Central  Google Scholar 

  32. Machado A Jr, Emodi K, Takenami I, Finkmoore BC, Barbosa T, Carvalho J, Cavalcanti L, Santos G, Tavares M, Mota M, Barreto F, Reis MG, Arruda S, Riley LW. Analysis of discordance between the tuberculin skin test and the interferon-γrelease assay. Int J Tuberc Lung Dis 2009; 13(4): 446–453

    PubMed  Google Scholar 

  33. Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M. Indeterminate results of QuantiFERON TB-2G test performed in routine clinical practice. Eur Respir J 2009; 33(4): 812–815

    Article  CAS  PubMed  Google Scholar 

  34. Lange B, Vavra M, Kern WV, Wagner D. Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients. Eur Respir J 2010; 35(5): 1179–1182

    Article  CAS  PubMed  Google Scholar 

  35. Zrinski Topic R, Zoricic-Letoja I, Pavic I, Dodig S. Indeterminate results of QuantiFERON-TB Gold In-Tube assay in nonimmunosuppressed children. Arch Med Res 2011; 42(2): 138–143

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Author notes

  1. These two authors contributed equally to this work.

Authors and Affiliations

  1. MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for Tuberculosis, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China

    Hengjing Li, Henan Xin, Xiangwei Li, Haoran Zhang, Mufei Li, Boxuan Feng, Qi Jin & Lei Gao

  2. Beijing Rehabilitation Hospital of Capital Medical University, Beijing, 100043, China

    Shukun Qian

Authors
  1. Hengjing Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henan Xin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shukun Qian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiangwei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haoran Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mufei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Boxuan Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Qi Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Lei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lei Gao.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Xin, H., Qian, S. et al. Testing of tuberculosis infection among Chinese adolescents born after terminating the Bacillus Calmette–Guérin booster vaccination: subgroup analysis of a population-based cross-sectional study. Front. Med. 11, 528–535 (2017). https://doi.org/10.1007/s11684-017-0573-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11684-017-0573-0

Keywords

Search

Navigation